TRDA Entrada Therapeutics Inc

USD 13.88 0.38 2.814815
Icon

Entrada Therapeutics Inc (TRDA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 13.88

+0.38 (+2.81)%

USD 0.41B

0.04M

USD 21.00(+51.30%)

USD 0.00 (-100.00%)

Icon

TRDA

Entrada Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 13.88
0.00 0
Take a Tour

Entrada Therapeutics Inc (TRDA) Stock Forecast

Show ratings and price targets of :
USD 21.00
(+51.30%)

Based on the Entrada Therapeutics Inc stock forecast from 2 analysts, the average analyst target price for Entrada Therapeutics Inc is USD 21.00 over the next 12 months. Entrada Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Entrada Therapeutics Inc is Slightly Bullish , which is based on 4 positive signals and 3 negative signals. At the last closing, Entrada Therapeutics Inc’s stock price was USD 13.88. Entrada Therapeutics Inc’s stock price has changed by +17.13% over the past week, +0.51% over the past month and +14.52% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...